Patent · US Active

Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide

US7658928B2 · kind B2 · utility

2Cited by

3References

6Claims

0Family size

Assignee

Intercell AG · AT

Inventors

Jörg Fritz · Wien, AT
Frank Mattner · Wien, AT
Wolfgang Zauner · Wien, AT
Michael Buschle · Perchtoldsdorf, AT
Alena Egyed · Wien, AT

Key dates

Filing date	Nov 29, 2007
Grant date	Feb 9, 2010
Priority date	—
Expiry date	Nov 29, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6031
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.